Objectıve: Rheumatic mitral stenosis (MS) is still a common disease in developing countries with high morbidity and mortality rates. The aim of the study was to evaluate left atrial mechanical functions in MS before and after percutaneous mitral balloon valvuloplasty (PMBV) and following in short and mid term. Methods: the study included 49 patients with critical mitral stenosis who have normal sinus rhythm (male/female:14 to 35; mean age: 42AE11). Left atrial mechanical functions were evaluated before, after, 3 months after and 1 year after PMBV, including Left atrial passive emptying volume (LAPEV), LA active emptying volume (LAAEV), LA total emptying volume (LATEV), LA passive emptying fraction (LAPEF), LA active emptying fraction (LAAEF), LA total emptying fraction (LATEF) and conduit volume (figure1). Results: The transthoracic echocardiography parameters of the mitral stenosis patients before, after, 3 months after and 1 year after percutaneous mitral balloon valvuloplasty were as follows: a) Mitral valve area: 1.1 cm 2 (0.9-1.6); 2.2 cm 2 (1. Conclusıon: our finding showed that improvement of left atrial mechanical functions after successful treatment of MS with PMBV and this improvement continues for one year.
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(28-57) (p<0.001); c) Left atrial passive emptying volume (LAPEV): 13 ml/m 2 (9-27); 11 ml/m 2 (8-19) (p<0.001); 10 ml/m 2 (7-19) (p<0.001); 10 ml/m 2 (6-18) (p<0.001);d) LA active emptying volume (LAAEV): 12 ml/m 2 (8-23); 10 ml/m 2 (6-21) (p<0.001); 9 ml/m 2 (5-17) (p<0.001); 9 ml/m 2 (4-16) (NS) e) LA total emptying volume (LATEV): 26 ml/m 2 (19-50); 21 ml/m 2 (16-40) (p<0.001); 20 ml/m 2 (15-36) (p<0.001); 19 ml/m 2 (15-34) p<0.001);f) Conduit volume: 30 ml/m 2 (22-44); 33 ml/ m 2 (26-46) p<0.001); 34 ml/m 2 (30-42) p<0.001); 36 ml/m 2 (31-42) p<0.001), respectively. However LA passive emptying fraction (LAPEF), LA active emptying fraction (LAAEF) and LA total emptying fraction (LATEF) were not altered after PMBV (table1).
Conclusıon: our finding showed that improvement of left atrial mechanical functions after successful treatment of MS with PMBV and this improvement continues for one year.
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Relation between Glycosylated Hemoglobin (Hemoglobin A1c) Background: Type 2 diabetes mellitus (DM) is a major risk factor for cardiovascular diseases and responsible for increased cardiovascular mortality. Chronic hyperglycemia is related with accelerated atherosclerosis. In this study, we tried to demonstrate the relation between glycosylated hemoglobin (HbA1c) level which is a marker of long standing hyperglycemia and aortic stiffness which is a marker of cardiovascular disease. Method and Results: 100 patients with newly diagnosis type 2 diabetes mellitus were included this study. The patients divided into 3 groups according to HbA1c level (Group 1 HbA1c 6, group 2 HbA1c 6-7 and group 3 HbA1c >7). Statistically significant difference was found between groups according to blood glucose level, DM duration and oral antidiabetic and insulin therapy (Table 1) . Aortic systolicdiastolic diameter, aortic strain and aortic distensibility were similar between group 1 and group 2 whereas in group 3, aortic systolic-diastolic diameter, aortic strain and aortic distensibility were significantly lower than group 1 and group 2 (p<0.001) ( Table 2 ). Significant correlation was found between aortic distensibility and HbA1c level (r¼0,283; p:0,004) (Figure 1) . Moreover, aortic distensibility was Comparison of before and after PMBV LA mechanic functional parameters measured by Transthoracic Echocardiography
